Thursday, July 21, 2016

BRIEF-Teva announces pricing of additional CHF1.0 billion of senior notes

* Teva announces pricing of additional CHF1.0 billion of senior notes in

connection with pending acquisition of actavis generics

Read more

No comments:

Post a Comment